Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01MYJ
|
|||
| Former ID |
DIB000815
|
|||
| Drug Name |
WT-4869
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1/2 | [1] | |
| Company |
Chugai Pharmaceutical Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Wilms tumor protein (WT1) | Target Info | Modulator | [2] |
| KEGG Pathway | Transcriptional misregulation in cancer | |||
| NetPath Pathway | FSH Signaling Pathway | |||
| IL5 Signaling Pathway | ||||
| Pathway Interaction Database | p73 transcription factor network | |||
| Regulation of Telomerase | ||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | |||
| Integrated Pancreatic Cancer Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033385) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033385) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.